Fibroblasts as Modulators of Local and Systemic Cancer Metabolism
Open accessThe DOI matches its Crossref record; 113 of the 115 references it cites were found in a registry or an index.
Abstract
Fibroblast activation is an accompanying feature of solid tumor progression, resembling a conserved host response to tissue damage. Cancer-associated fibroblasts (CAFs) comprise a heterogeneous and plastic population with increasingly appreciated roles in tumor growth, metastatic capacity, and response to therapy. Classical features of fibroblasts in a wound-healing response, including profound extracellular matrix production and cytokine release, are recapitulated in cancer. Emerging evidence suggests that fibroblastic cells in the microenvironments of solid tumors also critically modulate cellular metabolism in the neoplastic compartment through mechanisms including paracrine transfer of metabolites or non-cell-autonomous regulation of metabolic signaling pathways. These metabolic functions may represent common mechanisms by which fibroblasts stimulate growth of the regenerating epithelium during a wound-healing reaction, or may reflect unique co-evolution of cancer cells and surrounding stroma within the tumor microenvironment. Here we review the recent literature supporting an important role for CAFs in regulation of cancer cell metabolism, and relevant pathways that may serve as targets for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Autophagy in stromal fibroblasts can generate alanine, which is subsequently used by pancreatic ductal adenocarcinoma (PDAC) cells to fuel the tricarboxylic acid (TCA) cycle126,130,131.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kaur, A., Webster, M. R., Marchbank, K., Behera, R., Ndoye, A., Kugel, C. H., Dang, V. M., Appleton, J., O’Connell, M. P., Cheng, P., et al. (2016) · Nature · doi:10.1038/nature17392 · Cited by 398 · cited 1×
“The effect of age on the TME is so significant that genetically identical cells can have varying metastasis levels and therapy response based on whether they are in an aged TME or young TME, suggesting that the aged TME is capable of profoundly influencing cancer cell behavior [30].”
BackgroundRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“Cancer-associated fibroblasts (CAFs) derived from activated resident fibroblast pools or from mesenchymal progenitors recruited to the tumor microenvironment [2–4] have displayed diverse pro-tumorigenic functions that cooperate with cell-autonomous mechanisms to promote the hallmarks of cancer [5].”
BackgroundUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767 · cited 1×
“Abnormal whole-body metabolic responses to cancer include cancer cachexia, a potentially lethal wasting syndrome driven by negative energy balance and associated with loss of adipose and muscle tissue [62].”
BackgroundAccessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 1×
“CAFs are typically abundant in solid tumors [9], and are the principal producers of extracellular matrix (ECM) components and remodeling enzymes [10].”
BackgroundThe biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366 · cited 3×
“The increasingly appreciated role of activated fibroblasts in cancer progression and response to therapy [1] has prompted investigation of growth-permissive fibroblast functions in cancer.”
BackgroundÖzdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · cited 1×
“To probe the roles of the abundant CAF population in these tumors, the authors used genetic or pharmacologic approaches to ablate CAFs during pancreatic tumorigenesis, either ablating Shh-dependent CAFs [87,89] or αSMA-positive CAFs [88].”
BackgroundDistinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380 · cited 1×
“The hypoxia response is a universally conserved response to insufficient oxygen availability wherein the hypoxia-inducible factor (HIF) complex is stabilized and transported to hypoxia response element (HRE) promoter sequences to engage in transcription of over 100 genes, many of which are directly involved in increas…”
BackgroundProvenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195 · cited 1×
“This ECM has been shown to restrict vascular perfusion in the PDAC tumor microenvironment (TME) [17,18], and perhaps due to low serum availability, the PDAC milieu is nutrient-poor [19].”
BackgroundFeig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100 · cited 3×
“FAPα-positive cells in the primary tumor microenvironment have been associated with immune suppression, promoting T cell exclusion via secretion of CXCL12 [68].”
BackgroundInfluentialStromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085 · cited 2×
“Data are shown from systemic Shh inhibition, but the authors report that the same phenotype was observed in their genetic model which specifically targets Shh in the pancreas, and therefore specifically inhibits Shh-dependent CAFs within the local tumor microenvironment.”
BackgroundGlutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770 · cited 1×
“Upon malignant transformation, cancer cells become increasingly dependent on an exogenous supply of amino acids, especially glutamine, the most abundant amino acid in plasma [46].”
BackgroundMacropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683 · cited 1×
“Under conditions of low nutrients, mutant KRAS, a main oncogene of PDAC, is able to drive macropinocytosis as a source of amino acids from extracellular proteins for the cancer cells [20].”
BackgroundTargeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., De Saedeleer, C. J., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,624 · cited 1×
“Metabolic tracing experiments have shown that well-oxygenated cancer cells support high glycolysis rate of cells in hypoxia by increasing lactate uptake [34,35].”
BackgroundErez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515
The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391 · cited 5×
“Upon knockout of CAV1, fibroblasts gained myofibroblastic markers and increased rate of aerobic glycolysis [37].”
BackgroundInfluentialBiffi, G., Oni, T. E., Spielman, B., Hao, Y., Elyada, E., Park, Y., Preall, J., & Tuveson, D. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0710 · Cited by 1,360
Metabolic Instruction of Immunity
Buck, M. D., Sowell, R. T., Kaech, S. M., & Pearce, E. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.004 · Cited by 1,214
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Fearon, K. C. H., Glass, D. J., & Guttridge, D. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.011 · Cited by 1,205 · cited 2×
“The host metabolic perturbations associated with cancer progression have been partly attributed to increased systemic levels of pro-inflammatory cytokines [63].”
BackgroundSherman, M. H., Yu, R. T., Engle, D. D., Ding, N., Atkins, A. R., Tiriac, H., Collisson, E. A., Connor, F., Van Dyke, T., Kozlov, S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.007 · Cited by 1,158 · cited 2×
“By testing candidate recombinant proteins, the authors found that the 3 EGFR ligands discussed above—BTC, HB-EGF, and EREG—as well as PTHrP all stimulate thermogenic gene expression in primary adipocytes.”
BackgroundSelf-citationHallmarks of cancer: Interactions with the tumor stroma
Pietras, K., & Östman, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.045 · Cited by 1,141
Metabolic heterogeneity in human lung tumors
Hensley, C. T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.034 · Cited by 1,138
Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion
Dirat, B., Bochet, L., Dabek, M., Daviaud, D., Dauvillier, S., Majed, B., Wang, Y. Y., Meulle, A., Salles, B., Le Gonidec, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3323 · Cited by 1,134
Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
Sousa, C. M., Biancur, D. E., Wang, X., Halbrook, C. J., Sherman, M. H., Zhang, L., Kremer, D., Hwang, R. F., Witkiewicz, A. K., Ying, H., et al. (2016) · Nature · doi:10.1038/nature19084 · Cited by 1,122 · cited 3×
“Moreover, through the provision of alanine, CAFs further enhance carcinogenesis by allowing cancer cells to fuel TCA cycle, support lipid and NEAA synthesis, as well as diverting glucose metabolism to serine and glycine synthesis both of which are essential for cancer cell survival [44,48].”
BackgroundSelf-citationHyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302529 · Cited by 1,120
Serine and glycine metabolism in cancer
Amelio, I., Cutruzzolá, F., Antonov, A., Agostini, M., & Melino, G. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.004 · Cited by 1,056 · cited 1×
“Moreover, through the provision of alanine, CAFs further enhance carcinogenesis by allowing cancer cells to fuel TCA cycle, support lipid and NEAA synthesis, as well as diverting glucose metabolism to serine and glycine synthesis both of which are essential for cancer cell survival [44,48].”
BackgroundTumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism
Zhao, H., Yang, L., Baddour, J., Achreja, A., Bernard, V., Moss, T., Marini, J. C., Tudawe, T., Seviour, E. G., San Lucas, F. A., et al. (2016) · eLife · doi:10.7554/elife.10250 · Cited by 927 · cited 1×
“CAF-derived exosomes, CDEs, of prostate and pancreatic cancer have been shown to reprogram metabolism of cancer cells by significantly up-regulating glycolysis while down-regulating oxidative metabolism by promoting glutamine decarboxylation and at the same time generating metabolites for de novo lipogenesis [59].”
BackgroundKamphorst, J. J., Nofal, M., Commisso, C., Hackett, S. R., Lu, W., Grabocka, E., Vander Heiden, M. G., Miller, G., Drebin, J. A., Bar-Sagi, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2211 · Cited by 893 · cited 1×
“This ECM has been shown to restrict vascular perfusion in the PDAC tumor microenvironment (TME) [17,18], and perhaps due to low serum availability, the PDAC milieu is nutrient-poor [19].”
BackgroundGarin-Chesa, P., Old, L. J., & Rettig, W. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7235 · Cited by 748 · cited 1×
“Fibroblast activation protein-α (FAPα) marks activated fibroblastic cells in tumors [66] and other pathologic inflammatory conditions, including atherosclerosis [67].”
BackgroundCancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
Richards, K. E., Zeleniak, A. E., Fishel, M. L., Wu, J., Littlepage, L. E., & Hill, R. (2017) · Oncogene · doi:10.1038/onc.2016.353 · Cited by 735 · cited 1×
“CDEs have been shown to enhance gemcitabine resistance in pancreatic cancer cells by enhancing proliferation and glycolysis [60].”
Kamphorst, J. J., Cross, J. R., Fan, J., de Stanchina, E., Mathew, R., White, E. P., Thompson, C. B., & Rabinowitz, J. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307237110 · Cited by 726 · cited 1×
“Interestingly, metabolomic studies of KRAS mutant cells experiencing hypoxia demonstrate inability to undergo de novo lipogenesis and instead show more reliance on lipid scavenging, suggesting a potential metabolic function of lipids secreted by activated fibroblasts [53].”
BackgroundHypoxia and Metabolic Adaptation of Cancer Cells
Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724 · cited 1×
“Upon activation, quiescent fibroblasts undergo transcriptomic and metabolic programming that mimics the “Warburg Effect” metabolic phenotype, which is further exaggerated in the hypoxic TME [1,31,32] (Figure 2).”
BackgroundTumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia
Kir, S., White, J. P., Kleiner, S., Kazak, L., Cohen, P., Baracos, V. E., & Spiegelman, B. M. (2014) · Nature · doi:10.1038/nature13528 · Cited by 670 · cited 1×
“A recent study aimed to identify novel regulators of cancer cachexia, and found a novel connection between factors that promote adipose tissue browning and the onset of features of cachexia including weight loss and muscle atrophy [96].”
BackgroundEvidence for the involvement of interleukin 6 in experimental cancer cachexia.
Strassmann, G., Fong, M., Kenney, J. S., & Jacob, C. O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115767 · Cited by 658
Cancer associated fibroblasts: the dark side of the coin.
Cirri, P., & Chiarugi, P. (2011) · Europe PMC (PubMed Central) · Cited by 654
Mayers, J. R., Wu, C., Clish, C. B., Kraft, P., Torrence, M. E., Fiske, B. P., Yuan, C., Bao, Y., Townsend, M. K., Tworoger, S. S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3686 · Cited by 649 · cited 1×
“Cachexia is a common and early event in the pathogenesis of some cancer types, and evidence of tissue breakdown associated with cachexia may even be a biomarker of early tumorigenesis [64,65].”
BackgroundTissue of origin dictates branched-chain amino acid metabolism in mutant Kras -driven cancers
Mayers, J. R., Torrence, M. E., Danai, L. V., Papagiannakopoulos, T., Davidson, S. M., Bauer, M. R., Lau, A. N., Ji, B. W., Dixit, P. D., Hosios, A. M., et al. (2016) · Science · doi:10.1126/science.aaf5171 · Cited by 582
Fiaschi, T., Marini, A., Giannoni, E., Taddei, M. L., Gandellini, P., De Donatis, A., Lanciotti, M., Serni, S., Cirri, P., & Chiarugi, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1949 · Cited by 578 · cited 2×
“The same metabolic reprogramming has been shown in prostate cancer CAFs upon direct contact with cancer cells in co-culture studies [39].”
BackgroundStromal biology and therapy in pancreatic cancer: a changing paradigm
Neesse, A., Algül, H., Tuveson, D. A., & Gress, T. M. (2015) · Gut · doi:10.1136/gutjnl-2015-309304 · Cited by 559 · cited 13×
“This ECM has been shown to restrict vascular perfusion in the PDAC tumor microenvironment (TME) [17,18], and perhaps due to low serum availability, the PDAC milieu is nutrient-poor [19].”
BackgroundInfluentialStromal response to Hedgehog signaling restrains pancreatic cancer progression
Lee, J. J., Perera, R. M., Wang, H., Wu, D.-C., Liu, X. S., Han, S., Fitamant, J., Jones, P. D., Ghanta, K. S., Kawano, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411679111 · Cited by 502 · cited 2×
“Data are shown from systemic Shh inhibition, but the authors report that the same phenotype was observed in their genetic model which specifically targets Shh in the pancreas, and therefore specifically inhibits Shh-dependent CAFs within the local tumor microenvironment.”
BackgroundYang, L., Achreja, A., Yeung, T.-L., Mangala, L. S., Jiang, D., Han, C., Baddour, J., Marini, J. C., Ni, J., Nakahara, R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.011 · Cited by 429 · cited 2×
“In ovarian cancer, CAFs have been shown to harness carbon and nitrogen from aspartate, asparagine, and lactate to generate glutamine [47].”
BackgroundSqualene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death
Garcia-Bermudez, J., Baudrier, L., Bayraktar, E. C., Shen, Y., La, K., Guarecuco, R., Yucel, B., Fiore, D., Tavora, B., Freinkman, E., et al. (2019) · Nature · doi:10.1038/s41586-019-0945-5 · Cited by 424 · cited 1×
“Further roles of CAF lipid secretion remain to be elucidated as several lines of evidence suggest that exogenous lipids support auxotrophic cancer cell growth [56,57].”
BackgroundEffector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Wang, W., Kryczek, I., Dostál, L., Lin, H., Tan, L., Zhao, L., Lu, F., Wei, S., Maj, T., Peng, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.009 · Cited by 422
Roberts, E. W., Deonarine, A., Jones, J. O., Denton, A. E., Feig, C., Lyons, S. K., Espeli, M., Kraman, M., McKenna, B., Wells, R. J. B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122344 · Cited by 414 · cited 1×
“However, recent work using a FAPα reporter in mice showed that these FAPα-expressing fibroblastic cells can be found in numerous tissues in the adult mouse, including skeletal muscle [69].”
BackgroundGuillaumond, F., Leca, J., Olivares, O., Lavaut, M.-N., Vidal, N., Berthezène, P., Dusetti, N. J., Loncle, C., Calvo, E., Turrini, O., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219555110 · Cited by 413 · cited 1×
“Metabolic tracing experiments have shown that well-oxygenated cancer cells support high glycolysis rate of cells in hypoxia by increasing lactate uptake [34,35].”
BackgroundOlivares, O., Mayers, J. R., Gouirand, V., Torrence, M. E., Gicquel, T., Borge, L., Lac, S., Roques, J., Lavaut, M.-N., Berthezène, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms16031 · Cited by 413 · cited 1×
“Recent work has shown that the abundant, CAF-derived collagen in the PDAC ECM can serve as an extracellular protein source, and one particularly rich in prolines (25% of the amino acids in collagen) [21].”
BackgroundTumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy
Bertero, T., Oldham, W. M., Grasset, E. M., Bourget, I., Boulter, E., Pisano, S., Hofman, P., Bellvert, F., Meneguzzi, G., Bulavin, D. V., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.012 · Cited by 393
Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts
Ziani, L., Chouaib, S., & Thiery, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00414 · Cited by 381
Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
Flint, T. R., Janowitz, T., Connell, C. M., Roberts, E. W., Denton, A. E., Coll, A. P., Jodrell, D. I., & Fearon, D. T. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.010 · Cited by 367 · cited 1×
“Shining light on the role of IL6 in cancer cachexia, recent work demonstrated that the elevated IL6 in cachexia-associated tumor models suppresses hepatic ketogenesis, by downregulating expression of master ketogenic regulator PPARα in the liver [70].”
BackgroundWu, X., Tao, P., Zhou, Q., Li, J., Yu, Z., Wang, X., Li, J., Li, C., Yan, M., Zhu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15119 · Cited by 367
Bonetto, A., Aydogdu, T., Kunzevitzky, N., Guttridge, D. C., Khuri, S., Koniaris, L. G., & Zimmers, T. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022538 · Cited by 348 · cited 1×
“Further, activation of STAT3 downstream of IL6 has been linked to muscle wasting in cancer [81].”
BackgroundMechanisms of metabolic dysfunction in cancer-associated cachexia
Petruzzelli, M., & Wagner, E. F. (2016) · Genes & Development · doi:10.1101/gad.276733.115 · Cited by 340 · cited 1×
“Beyond metabolic dysregulation in its local tissue context, cancer is associated with metabolic alterations in the host [61].”
BackgroundMetabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α Downregulation
Zhang, D., Wang, Y., Shi, Z., Liu, J., Sun, P., Hou, X., Zhang, J., Zhao, S., Zhou, B. P., & Mi, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.006 · Cited by 333 · cited 3×
“α-KG and oxygen are critical co-factors for PHD enzymes, which negatively regulate stability of glycolysis master regulator HIF1α by promoting its ubiquitin-mediated proteosome degradation in normoxia [40,41].”
BackgroundA Stromal Lysolipid–Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression
Auciello, F. R., Bulusu, V., Oon, C., Tait-Mulder, J., Berry, M., Bhattacharyya, S., Tumanov, S., Allen-Petersen, B. L., Link, J., Kendsersky, N. D., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1212 · Cited by 332 · cited 1×
“Recently, work from our lab demonstrated that activated stellate cells secrete abundant lysophosphatidylcholines (LPC), the preferred fatty acid scavenging substrate for RAS-transformed cells, which can support PDAC cells growth both via uptake and biomass production and via hydrolysis by the secreted enzyme autotaxin…”
BackgroundSelf-citationHepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
Li, T., Yang, Y., Hua, X., Wang, G., Liu, W., Jia, C., Tai, Y., Zhang, Q., & Chen, G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.020 · Cited by 328 · cited 1×
“PGE2 and IDO secretion by CAFs affects NK cells by decreasing their cytotoxicity against cancer cells [28].”
BackgroundGui, D. Y., Sullivan, L. B., Luengo, A., Hosios, A. M., Bush, L. N., Gitego, N., Davidson, S. M., Freinkman, E., Thomas, C. J., & Vander Heiden, M. G. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.006 · Cited by 323
Guido, C., Whitaker-Menezes, D., Capparelli, C., Balliet, R., Lin, Z., Pestell, R. G., Howell, A., Aquila, S., Andò, S., Martinez-Outschoorn, U., et al. (2012) · Cell Cycle · doi:10.4161/cc.21384 · Cited by 319 · cited 2×
“autophagy/mitophagy, and aerobic glycolysis—all known factors enhancing HIF1α stability [42,43].”
BackgroundValencia, T., Kim, J. Y., Abu-Baker, S., Moscat-Pardos, J., Ahn, C. S., Reina-Campos, M., Duran, A., Castilla, E. A., Metallo, C. M., Diaz-Meco, M. T., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.004 · Cited by 304 · cited 1×
“In contrast to autophagy activation in pancreatic cancer, genetic analyses of prostate and liver tumor stroma shows a decrease of autophagy substrate signaling adaptor protein, p62, resulting in defective autophagy [49,50].”
BackgroundGangoda, L., Boukouris, S., Liem, M., Kalra, H., & Mathivanan, S. (2015) · PROTEOMICS · doi:10.1002/pmic.201400234 · Cited by 301 · cited 1×
“Recent studies have shown that exosomes carry proteins, nucleic acids, miRNAs, and metabolic molecules [58].”
BackgroundFibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis
Curtis, M., Kenny, H. A., Ashcroft, B., Mukherjee, A., Johnson, A., Zhang, Y., Helou, Y., Batlle, R., Liu, X., Gutierrez, N., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.007 · Cited by 290 · cited 1×
“CAF-derived cytokines including CCL5, IL6, and CXCL10 can also regulate cancer cell metabolism by promoting phosphorylation of phosphoglucomutase 1 and increasing glycogen mobilization in cancer cells, promoting NADPH synthesis and the TCA cycle and thus enabling cancer cell proliferation and metastatic spread of ovar…”
BackgroundBone marrow–derived fibroblasts are a functionally distinct stromal cell population in breast cancer
Raz, Y., Cohen, N., Shani, O., Bell, R. E., Novitskiy, S. V., Abramovitz, L., Levy, C., Milyavsky, M., Leider-Trejo, L., Moses, H. L., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180818 · Cited by 268
Fu, Y., Liu, S., Yin, S., Niu, W., Xiong, W., Tan, M., Li, G., & Zhou, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18175 · Cited by 263 · cited 1×
“In the context of tumor metabolism, this phenomenon has been dubbed as the “Reverse Warburg Effect,” from the perspective of cancer cells reacting to metabolic reprogramming in CAFs [36].”
BackgroundZhang, Y., Yan, W., Collins, M. A., Bednar, F., Rakshit, S., Zetter, B. R., Stanger, B. Z., Chung, I., Rhim, A. D., & di Magliano, M. P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1558-t · Cited by 261
Extracellular Matrix Remodeling Regulates Glucose Metabolism through TXNIP Destabilization
Sullivan, W. J., Mullen, P. J., Schmid, E. W., Flores, A., Momcilovic, M., Sharpley, M. S., Jelinek, D., Whiteley, A. E., Maxwell, M. B., Wilde, B. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.017 · Cited by 259
Duran, A., Hernandez, E. D., Reina-Campos, M., Castilla, E. A., Subramaniam, S., Raghunandan, S., Roberts, L. R., Kisseleva, T., Karin, M., Diaz-Meco, M. T., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.004 · Cited by 239 · cited 1×
“In contrast to autophagy activation in pancreatic cancer, genetic analyses of prostate and liver tumor stroma shows a decrease of autophagy substrate signaling adaptor protein, p62, resulting in defective autophagy [49,50].”
BackgroundNon-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer
Iommarini, L., Porcelli, A. M., Gasparre, G., & Kurelac, I. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00286 · Cited by 231 · cited 1×
“α-KG and oxygen are critical co-factors for PHD enzymes, which negatively regulate stability of glycolysis master regulator HIF1α by promoting its ubiquitin-mediated proteosome degradation in normoxia [40,41].”
BackgroundStaal-van den Brekel, A. J., Dentener, M. A., Schols, A. M., Buurman, W. A., & Wouters, E. F. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.10.2600 · Cited by 218
Duluc, C., Moatassim‐Billah, S., Chalabi‐Dchar, M., Perraud, A., Samain, R., Breibach, F., Gayral, M., Cordelier, P., Delisle, M., Bousquet‐Dubouch, M., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404346 · Cited by 214
Black, K., Garrett, I. R., & Mundy, G. R. (1991) · Endocrinology · doi:10.1210/endo-128-5-2657 · Cited by 199
Rattigan, Y. I., Patel, B. B., Ackerstaff, E., Sukenick, G., Koutcher, J. A., Glod, J. W., & Banerjee, D. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.11.014 · Cited by 196 · cited 1×
“The “Reverse Warburg Effect” does not reflect all metabolic crosstalk across fibrotic tumors as evidenced by studies in breast and pancreatic cancer showing CAFs increasing lactate uptake and re-purposing it for bioenergetics [44,45].”
BackgroundMetabolic Signaling to the Nucleus in Cancer
Campbell, S. L., & Wellen, K. E. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.015 · Cited by 181 · cited 1×
“As cancer cells exhibit metabolic plasticity [110,111], therapies targeting metabolism-modulating pathways will likely need to target parallel mechanisms fulfilling bioenergetic needs, or to combine metabolic inhibitors with therapeutic interventions that suppress cancer cell plasticity and thus the capacity for metab…”
BackgroundSotgia, F., Martinez-Outschoorn, U. E., Pavlides, S., Howell, A., Pestell, R. G., & Lisanti, M. P. (2011) · Breast Cancer Research · doi:10.1186/bcr2892 · Cited by 177 · cited 2×
“Further analysis demonstrated that the metabolic program of CAFs in breast cancer is supported by cancer cells’ increased lactate uptake to support their own bioenergetic needs [37,38].”
BackgroundTsoli, M., Moore, M., Burg, D., Painter, A., Taylor, R., Lockie, S. H., Turner, N., Warren, A., Cooney, G., Oldfield, B., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3536 · Cited by 172
Bing, C., Brown, M., King, P., Collins, P., Tisdale, M. J., & Williams, G. (2000) · PubMed · Cited by 170
Brokopp, C. E., Schoenauer, R., Richards, P., Bauer, S., Lohmann, C., Emmert, M. Y., Weber, B., Winnik, S., Aikawa, E., Graves, K., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq519 · Cited by 166 · cited 1×
“Fibroblast activation protein-α (FAPα) marks activated fibroblastic cells in tumors [66] and other pathologic inflammatory conditions, including atherosclerosis [67].”
BackgroundQiao, Y., Zhang, C., Li, A., Wang, D., Luo, Z., Ping, Y., Zhou, B., Liu, S., Li, H., Yue, D., et al. (2018) · Oncogene · doi:10.1038/onc.2017.387 · Cited by 166
Cytokines in the pathogenesis of cancer cachexia
Argilés, J. M., Busquets, S., & López-Soriano, F. J. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000078983.18774.cc · Cited by 165
Tsujinaka, T., Ebisui, C., Fujita, J., Kishibuchi, M., Morimoto, T., Ogawa, A., Katsume, A., Ohsugi, Y., Kominami, E., & Monden, M. (1995) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.1995.1168 · Cited by 159
Hsu, Y.-L., Hung, J.-Y., Chiang, S.-Y., Jian, S.-F., Wu, C.-Y., Lin, Y.-S., Tsai, Y.-M., Chou, S.-H., Tsai, M.-J., & Kuo, P.-L. (2016) · Oncotarget · doi:10.18632/oncotarget.8488 · Cited by 158 · cited 1×
“In lung cancer, TDO2 secretion by CAFs promotes tryptophan metabolism to kynurenines (Kyn), inhibiting DC differentiation while VEGF secretion inhibits DC generation and maturation by reducing MHC class II expression and antigen presenting abilities [29].”
BackgroundMouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism
Wang, J., & Dunn, A. J. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00016-3 · Cited by 151 · cited 1×
“Notably, IL6 can also directly regulate the hypothalamic-pituitary-adrenal axis [86], and may further contribute to cachexia through its activity in the brain.”
BackgroundTumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences
Paunescu, V., Bojin, F. M., Tatu, C. A., Gavriliuc, O. I., Rosca, A., Gruia, A. T., Tanasie, G., Bunu, C., Crisnic, D., Gherghiceanu, M., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01044.x · Cited by 150
Elevated Serum Interleukin-6 Levels in Patients with Pancreatic Cancer
Okada, S., Okusaka, T., Ishii, H., Kyogoku, A., Yoshimori, M., Kajimura, N., Yamaguchi, K., & Kakizoe, T. (1998) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/28.1.12 · Cited by 149
Stromal cues regulate the pancreatic cancer epigenome and metabolome
Sherman, M. H., Yu, R. T., Tseng, T. W., Sousa, C. M., Liu, S., Truitt, M. L., He, N., Ding, N., Liddle, C., Atkins, A. R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620164114 · Cited by 147 · cited 1×
“Consistent with this study, soluble CAF-derived proteins together with 3D type I collagen induce transcriptional and metabolic alterations in PDAC cells supporting anabolic programs, which overlaps significantly with networks regulated by oncogenic KRAS and suggests points of convergence between cell-intrinsic and mic…”
Self-citationFEARON, K. C. H., MCMILLAN, D. C., PRESTON, T., WINSTANLEY, F. P., CRUICKSHANK, A. M., & SHENKIN, A. (1991) · Annals of Surgery · doi:10.1097/00000658-199101000-00005 · Cited by 140
Strassmann, G., Fong, M., Freter, C. E., Windsor, S., D'Alessandro, F., & Nordan, R. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116816 · Cited by 131
Exploring Metabolic Configurations of Single Cells within Complex Tissue Microenvironments
Miller, A., Nagy, C., Knapp, B., Laengle, J., Ponweiser, E., Gröger, M., Starkl, P. M., Bergmann, M. M., Wagner, O. F., & Haschemi, A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.014 · Cited by 123
Muir, A., Danai, L. V., & Vander Heiden, M. G. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035758 · Cited by 121
Brown adipose tissue in cancer patients: Possible cause of cancer-induced cachexia
Shellock, F. G., Riedinger, M. S., & Fishbein, M. C. (1986) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00402783 · Cited by 119
Tumor fibroblast–derived epiregulin promotes growth of colitis-associated neoplasms through ERK
Neufert, C., Becker, C., Türeci, Ö., Waldner, M. J., Backert, I., Floh, K., Atreya, I., Leppkes, M., Jefremow, A., Vieth, M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63748 · Cited by 115 · cited 2×
“By testing candidate recombinant proteins, the authors found that the 3 EGFR ligands discussed above—BTC, HB-EGF, and EREG—as well as PTHrP all stimulate thermogenic gene expression in primary adipocytes.”
BackgroundUpregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells
Fuyuhiro, Y., Yashiro, M., Noda, S., Kashiwagi, S., Matsuoka, J., Doi, Y., Kato, Y., Hasegawa, T., Sawada, T., & Hirakawa, K. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.330 · Cited by 114 · cited 2×
“autophagy/mitophagy, and aerobic glycolysis—all known factors enhancing HIF1α stability [42,43].”
BackgroundATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the p62-Deficient Tumor Stroma
Linares, J. F., Cordes, T., Duran, A., Reina-Campos, M., Valencia, T., Ahn, C. S., Castilla, E. A., Moscat, J., Metallo, C. M., & Diaz-Meco, M. T. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.001 · Cited by 111 · cited 2×
“ATF4-positive CAFs support neoplastic cell growth in low glutamine conditions through activation of the pyruvate carboxylase-asparagine synthase pathway [51].”
BackgroundMetabolic exchanges within tumor microenvironment
Chiarugi, P., & Cirri, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.027 · Cited by 109 · cited 1×
“More recently, however, evidence has emerged to support a critical role for CAFs as regulators of critical metabolic processes in cancer [14].”
BackgroundStellate Cells in Tissue Repair, Inflammation, and Cancer
Sherman, M. H. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062855 · Cited by 103 · cited 1×
“Interestingly, a well-known feature of particular pancreatic fibroblasts and hepatic fibroblasts, known as pancreatic and hepatic stellate cells, is their ability to store lipids in their quiescent phenotype [52].”
BackgroundSelf-citationTumor-Derived Ligands Trigger Tumor Growth and Host Wasting via Differential MEK Activation
Song, W., Kır, S., Hong, S., Hu, Y., Wang, X., Binari, R. C., Tang, H.-W., Chung, V., Banks, A. S., Spiegelman, B. M., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2018.12.003 · Cited by 98 · cited 1×
“Activation of EGFR/MEK signaling in the primary tumor has been recently linked to MEK activation and wasting in host tissues [102], and while CAFs as a source for these ligands or for PTHrP have not been specifically addressed, EGFR signaling has been functionally linked to cachexia and/or energy expenditure in additi…”
BackgroundMurata, T., Mizushima, H., Chinen, I., Moribe, H., Yagi, S., Hoffman, R. M., Kimura, T., Yoshino, K., Ueda, Y., Enomoto, T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0034 · Cited by 91 · cited 2×
“By testing candidate recombinant proteins, the authors found that the 3 EGFR ligands discussed above—BTC, HB-EGF, and EREG—as well as PTHrP all stimulate thermogenic gene expression in primary adipocytes.”
BackgroundHulea, L., Gravel, S.-P., Morita, M., Cargnello, M., Uchenunu, O., Im, Y. K., Lehuédé, C., Ma, E. H., Leibovitch, M., McLaughlan, S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.001 · Cited by 91 · cited 1×
“As cancer cells exhibit metabolic plasticity [110,111], therapies targeting metabolism-modulating pathways will likely need to target parallel mechanisms fulfilling bioenergetic needs, or to combine metabolic inhibitors with therapeutic interventions that suppress cancer cell plasticity and thus the capacity for metab…”
BackgroundCachexia and Brown Fat: A Burning Issue in Cancer
Kir, S., & Spiegelman, B. M. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.07.005 · Cited by 87 · cited 1×
“Cachexia is characterized in part by increased resting energy expenditure, which has been linked to increased thermogenesis by brown adipose tissue [97–100] and to browning of white adipose tissue [101].”
Sympathetic activation of brown-adipose-tissue thermogenesis in cachexia
Brooks, S. L., Neville, A. M., Rothwell, N. J., Stock, M. J., & Wilson, S. (1981) · Bioscience Reports · doi:10.1007/bf01121584 · Cited by 85
Ohe, Y., Podack, E., Olsen, K., Miyahara, Y., Miura, K., Saito, H., Koishihara, Y., Ohsugi, Y., Ohira, T., Nishio, K., et al. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.174 · Cited by 79
Tamura, S., Ouchi, K. F., Mori, K., Endo, M., Matsumoto, T., Eda, H., Tanaka, Y., Ishitsuka, H., Tokita, H., & Yamaguchi, K. (1995) · PubMed · Cited by 66
Towards discovery‐driven translational research in breast cancer
Celis, J. E., Moreira, J. M. A., Gromova, I., Cabezón, T., Ralfkiær, U., Guldberg, P., Straten, P. T., Mouridsen, H. T., Friis, E., Holm, D. K., et al. (2004) · FEBS Journal · doi:10.1111/j.1432-1033.2004.04418.x · Cited by 53
LDL Receptor: An open route to feed pancreatic tumor cells
Vasseur, S., & Guillaumond, F. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1033586 · Cited by 48 · cited 1×
“Further roles of CAF lipid secretion remain to be elucidated as several lines of evidence suggest that exogenous lipids support auxotrophic cancer cell growth [56,57].”
BackgroundAddressing metabolic heterogeneity in clear cell renal cell carcinoma with quantitative Dixon MRI
Zhang, Y., Udayakumar, D., Cai, L., Hu, Z., Kapur, P., Kho, E.-Y., Pavía-Jiménez, A., Fulkerson, M., de Leon, A. D., Yuan, Q., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.94278 · Cited by 44
Blomme, E. A. G., Sugimoto, Y., Lin, Y. C., Capen, C. C., & Rosol, T. J. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00252-4 · Cited by 43 · cited 1×
“CAFs and normal fibroblasts are also prominent producers of parathyroid hormone-related protein (PTHrP) [93,94], a developmental regulatory molecule activated by EGFR signaling [95].”
BackgroundPEDF regulates plasticity of a novel lipid–MTOC axis in prostate cancer-associated fibroblasts
Nardi, F., Fitchev, P., Franco, O. E., Ivanisevic, J., Scheibler, A., Hayward, S. W., Brendler, C. B., Welte, M. A., & Crawford, S. E. (2018) · Journal of Cell Science · doi:10.1242/jcs.213579 · Cited by 27 · cited 1×
“Reprogramming of lipid metabolism has also been demonstrated in prostate CAFs compared to normal prostate fibroblasts [55].”
BackgroundAnti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma
Hicks, M. J., Chiuchiolo, M. J., Ballon, D., Dyke, J. P., Aronowitz, E., Funato, K., Tabar, V. S., Havlicek, D. F., Fan, F., Sondhi, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162978 · Cited by 25 · cited 1×
“Activation of EGFR/MEK signaling in the primary tumor has been recently linked to MEK activation and wasting in host tissues [102], and while CAFs as a source for these ligands or for PTHrP have not been specifically addressed, EGFR signaling has been functionally linked to cachexia and/or energy expenditure in additi…”
BackgroundBricon, T. L. (1996) · Clinical Nutrition · doi:10.1016/s0261-5614(96)80245-7 · Cited by 18
Kitagawa, M., Haji, S., & Amagai, T. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617724742 · Cited by 18 · cited 1×
“Cachexia is a common and early event in the pathogenesis of some cancer types, and evidence of tissue breakdown associated with cachexia may even be a biomarker of early tumorigenesis [64,65].”
BackgroundAt the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone
Foley, J., Nickerson, N. K., Riese, D. J., Hollenhorst, P. C., Lorch, G., & Foley, A. M. (2012) · Odontology · doi:10.1007/s10266-012-0070-5 · Cited by 14 · cited 1×
“CAFs and normal fibroblasts are also prominent producers of parathyroid hormone-related protein (PTHrP) [93,94], a developmental regulatory molecule activated by EGFR signaling [95].”
BackgroundCros, M., Cataisson, C., Cho, Y. M., Berthois, Y., Bernard-Poenaru, O., Denne, M. A., Graulet, A. M., de Vernejoul, M. C., Foley, J., & Bouizar, Z. (2002) · PubMed · Cited by 9
Epiregulin induces leptin secretion and energy expenditure in high-fat diet-fed mice
Yasmeen, R., Shen, Q., Lee, A., Leung, J. H., Kowdley, D., DiSilvestro, D. J., Xu, L., Yang, K., Maiseyeu, A., Bal, N. C., et al. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0289 · Cited by 9 · cited 1×
“Activation of EGFR/MEK signaling in the primary tumor has been recently linked to MEK activation and wasting in host tissues [102], and while CAFs as a source for these ligands or for PTHrP have not been specifically addressed, EGFR signaling has been functionally linked to cachexia and/or energy expenditure in additi…”
Background
Cited by
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863
Self-citationTumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“Since antitumor immunity suppression is progressively tied to key metabolic pathways' activities and intratumoral metabolite levels in immune cells [227] , the way by which CAF secretome could affect metabolism and immune cells function in the TME requires further investigation [228] .”
BackgroundThe cancer-immunity cycle: Indication, genotype, and immunotype
Mellman, I., Chen, D. S., Powles, T., & Turley, S. J. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.011 · Cited by 953
Fibroblasts in cancer: Unity in heterogeneity
Chhabra, Y., & Weeraratna, A. T. (2023) · Cell · doi:10.1016/j.cell.2023.03.016 · Cited by 474
Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
Li, Z., Sun, C., & Qin, Z. (2021) · Theranostics · doi:10.7150/thno.62378 · Cited by 390
Metadata
- Authors
- Sanford-Crane, H., Abrego, J., & Sherman, M. H.
- Affiliations
- Oregon Health & Science University (US)
- Corresponding author
- Sherman, Mara H.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2019-05-03
- Volume
- 11
- Issue
- 5
- Pages
- 619
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC6562905
- OpenAlex
- W2943306398
- Cited by
- 77
- References
- 115
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 9 · 2022: 12 · 2021: 17 · 2020: 20 · 2019: 2
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Cancer Institute (CA188259, CA229580)
- American Cancer Society (132898-RSG-18-142-01-CSM)
- V Foundation for Cancer Research (V Scholar Award)
- DOD Peer Reviewed Cancer Research Program (W81XWH-18-1-0437)
- Hirshberg Foundation for Pancreatic Cancer Research (Seed Grant)
- Medical Research Foundation (New Investigator Grant)
- Oregon Health and Science University (Brenden-Colson Center Pilot Award, Cancer Early Detection Advanced Research Pilot Award, Fellowship for Diversity in Research)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, cancer metabolism, fibroblast activation, extracellular matrix, wound healing, non-cell-autonomous signaling, tumor stroma, metastasis, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.